APA (7th ed.) Citation

Erard, D., Steiner, A., Boillot, O., Thimonier, E., Vallin, M., Veyre, F., . . . Dumortier, J. (2024). Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease. Wiley. https://doi.org/10.1111/ctr.70014

Chicago Style (17th ed.) Citation

Erard, Domitille, Anouk Steiner, Olivier Boillot, Elsa Thimonier, Mélanie Vallin, Florian Veyre, Olivier Guillaud, Sylvie Radenne, and Jérôme Dumortier. Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease. Wiley, 2024. https://doi.org/10.1111/ctr.70014.

MLA (9th ed.) Citation

Erard, Domitille, et al. Calcineurin‐Inhibitor Discontinuation Could Reduce the Risk of De Novo Malignancies After Liver Transplantation for Alcohol‐Related Liver Disease. Wiley, 2024. https://doi.org/10.1111/ctr.70014.